Vertex Pharmaceuticals Incorporated (VRTX)
After hours:
| Previous close | 354.28 |
| Open | 351.76 |
| Bid | 348.00 x 2200 |
| Ask | 358.06 x 800 |
| Day's range | 348.41 - 355.25 |
| 52-week range | 276.57 - 367.00 |
| Volume | |
| Avg. volume | 1,013,408 |
| Market cap | 90.212B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 26.89 |
| EPS (TTM) | 13.00 |
| Earnings date | 25 Oct 2023 - 30 Oct 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 387.08 |
Motley Fool3 Magnificent Growth Stocks to Buy Right Now
Three Fool.com contributors believe they've identified truly magnificent growth stocks to buy right now. Here's why they chose AstraZeneca (NASDAQ: AZN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (AstraZeneca): What makes AstraZeneca a magnificent long-term investment is how broad the business is and the potential it has to generate long-term gains.
Motley Fool2 Healthcare Stocks That Could Make You Richer
There are many ways one can become richer, from trying to buy a winning lottery ticket to pouncing on some get-rich-quick scheme. Unfortunately, none of these methods is very reliable at all, unlike investing in equities. The stock market is for those who are willing to wait, and it won't increase one's wealth substantially overnight.
Motley Fool3 Unstoppable Stocks to Buy and Hold for the Next 20 Years
Buying stocks is easy. President Joe Biden has called the next 10 years America's "infrastructure decade." There will be plenty of winners with the major global emphasis on infrastructure in the coming years.
